Investors Seek Second Act with Moderna Stock

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Moderna hopes its combination vaccine for COVID and the flu can keep profits high but investors are skeptical. MRNA stock struck gold with its Covid-19 vaccine but investors want to know if there are any other blockbusters in its pipeline.

The post Investors Seek Second Act with Moderna Stock appeared first on InvestorPlace.

• Get in Now on Tiny $3 ‘Forever Battery’ Stock
• It doesn’t matter if you have $500 in savings or $5 million. Do this now.
• Stock Prodigy Who Found NIO at $2… Says Buy THIS
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”